249 related articles for article (PubMed ID: 26525393)
1. Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.
Herwig R; Gmuender H; Corvi R; Bloch KM; Brandenburg A; Castell J; Ceelen L; Chesne C; Doktorova TY; Jennen D; Jennings P; Limonciel A; Lock EA; McMorrow T; Phrakonkham P; Radford R; Slattery C; Stierum R; Vilardell M; Wittenberger T; Yildirimman R; Ryan M; Rogiers V; Kleinjans J
Arch Toxicol; 2016 Sep; 90(9):2215-2229. PubMed ID: 26525393
[TBL] [Abstract][Full Text] [Related]
2. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
[TBL] [Abstract][Full Text] [Related]
3. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.
Melis JP; Derks KW; Pronk TE; Wackers P; Schaap MM; Zwart E; van Ijcken WF; Jonker MJ; Breit TM; Pothof J; van Steeg H; Luijten M
Arch Toxicol; 2014 Apr; 88(4):1023-34. PubMed ID: 24390151
[TBL] [Abstract][Full Text] [Related]
4. Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion.
Jennings P; Aydin S; Bennett J; McBride R; Weiland C; Tuite N; Gruber LN; Perco P; Gaora PO; Ellinger-Ziegelbauer H; Ahr HJ; Kooten CV; Daha MR; Prieto P; Ryan MP; Pfaller W; McMorrow T
Toxicol In Vitro; 2009 Apr; 23(3):486-99. PubMed ID: 19159671
[TBL] [Abstract][Full Text] [Related]
5. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning.
Auerbach SS; Shah RR; Mav D; Smith CS; Walker NJ; Vallant MK; Boorman GA; Irwin RD
Toxicol Appl Pharmacol; 2010 Mar; 243(3):300-14. PubMed ID: 20004213
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.
Eichner J; Wrzodek C; Römer M; Ellinger-Ziegelbauer H; Zell A
PLoS One; 2014; 9(5):e97678. PubMed ID: 24828355
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomics discrimination of potential hepatocarcinogenicity of non-genotoxic compounds in rat liver.
Yamada F; Sumida K; Uehara T; Morikawa Y; Yamada H; Urushidani T; Ohno Y
J Appl Toxicol; 2013 Nov; 33(11):1284-93. PubMed ID: 22806939
[TBL] [Abstract][Full Text] [Related]
8. Assessing compound carcinogenicity in vitro using connectivity mapping.
Caiment F; Tsamou M; Jennen D; Kleinjans J
Carcinogenesis; 2014 Jan; 35(1):201-7. PubMed ID: 23940306
[TBL] [Abstract][Full Text] [Related]
9. The Carcinogenome Project: In Vitro Gene Expression Profiling of Chemical Perturbations to Predict Long-Term Carcinogenicity.
Li A; Lu X; Natoli T; Bittker J; Sipes NS; Subramanian A; Auerbach S; Sherr DH; Monti S
Environ Health Perspect; 2019 Apr; 127(4):47002. PubMed ID: 30964323
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
11. Inferring transcription factor activity from microarray data reveals novel targets for toxicological investigations.
Souza TM; van den Beucken T; Kleinjans JCS; Jennen DGJ
Toxicology; 2017 Aug; 389():101-107. PubMed ID: 28743512
[TBL] [Abstract][Full Text] [Related]
12. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
[TBL] [Abstract][Full Text] [Related]
13. Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity.
Rieswijk L; Brauers KJ; Coonen ML; Jennen DG; van Breda SG; Kleinjans JC
Mutagenesis; 2016 Sep; 31(5):603-15. PubMed ID: 27338304
[TBL] [Abstract][Full Text] [Related]
14. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific mRNA signatures as fingerprints for carcinogenesis in mice induced by genotoxic and nongenotoxic hepatocarcinogens.
Kossler N; Matheis KA; Ostenfeldt N; Bach Toft D; Dhalluin S; Deschl U; Kalkuhl A
Toxicol Sci; 2015 Feb; 143(2):277-95. PubMed ID: 25410580
[TBL] [Abstract][Full Text] [Related]
16. Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity.
Yildirimman R; Brolén G; Vilardell M; Eriksson G; Synnergren J; Gmuender H; Kamburov A; Ingelman-Sundberg M; Castell J; Lahoz A; Kleinjans J; van Delft J; Björquist P; Herwig R
Toxicol Sci; 2011 Dec; 124(2):278-90. PubMed ID: 21873647
[TBL] [Abstract][Full Text] [Related]
17. How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study.
Anthony Tony Cox L; Popken DA; Kaplan AM; Plunkett LM; Becker RA
Regul Toxicol Pharmacol; 2016 Jun; 77():54-64. PubMed ID: 26879462
[TBL] [Abstract][Full Text] [Related]
18. Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells.
Li HH; Hyduke DR; Chen R; Heard P; Yauk CL; Aubrecht J; Fornace AJ
Environ Mol Mutagen; 2015 Jul; 56(6):505-19. PubMed ID: 25733355
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of DNA microarray results in the Toxicogenomics Project (TGP) consortium in Japan.
Noriyuki N; Igarashi Y; Ono A; Yamada H; Ohno Y; Urushidani T
J Toxicol Sci; 2012; 37(4):791-801. PubMed ID: 22863858
[TBL] [Abstract][Full Text] [Related]
20. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
Uehara T; Minowa Y; Morikawa Y; Kondo C; Maruyama T; Kato I; Nakatsu N; Igarashi Y; Ono A; Hayashi H; Mitsumori K; Yamada H; Ohno Y; Urushidani T
Toxicol Appl Pharmacol; 2011 Sep; 255(3):297-306. PubMed ID: 21784091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
